In a clinical trial testing an experimental
enzyme regimen against
gemcitabine-based chemotherapy for
advanced pancreatic cancer, people
receiving chemotherapy lived an average
of 9.7 months longer. The results
are published in the Journal of Clinical
Oncology.
Read More
It is hard to stage pancreatic cancer
accurately by imaging tests.
Doctors must do their best to decide
before surgery whether there is a
good chance the cancer can be completely
removed. Surgeons usually
consider a pancreatic cancer
resectable
(completely removable by surgery) if it
is staged as T1, T2, or T3. That means
it doesn’t extend far beyond the pancreas,
especially into nearby large blood
vessels (T4). There is no accurate way
to assess the lymph node spread of the
tumor before surgery.
Read More